Adenosine analogs inhibit the guanine-7-methylation of mRNA cap structures  by Oxenrider, Keith A. et al.
Volume 316, number 3,273-277 FEBS 12065 
0 1993 Federation of European Biochemical Societies 00145793/93/$6.00 
February 1993 
Adenosine analogs inhibit the guanine-7-methylation of mRNA cap 
structures 
Keith A. Oxenrider, Guojun Bu and Thomas 0. Sitz 
Department of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA 
Received 10 December 1992 
The adenosine analogs neplanocin A and deazaneplanocin A were observed to inhibit the in vivo guanine-7-methylation f mRNA cap structure 
using a new assay for hypomethylated RNA. Treatment of cultured mammalian cells with these adenosine analogs resulted in the same extent of 
hypomethylation of cap structure as did ethionine injection in mice. Neplanocin A and its non-metabolizable analog 3deazaneplanocin A show 
the same maximal evel of inhibition of methylation suggesting that these adenosine analogs exert their effects by elevating S-adenosylhomocysteine 
levels rather than by conversion to other inhibitory compounds. 
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1. INTRODUCTION 
Eucaryotic mRNAs contain a S-cap structure 
(G”pppX,pN,pN---) which is highly modified via the 
methylation of both base and ribose components of its 
nucleotides [l]. This cap structure plays an important 
role in directing the splicing of the mRNA precursors 
[2] and in the initiation of translation [3,4]. Among the 
most important of these methylations is that of the 7- 
position of the guanine base, as the cap is not functional 
without it [2,5]. The roles of the other cap methylations 
and the methylation of internal bases such as N6-meth- 
yladenosine are not clear, but may play a role in proc- 
essing and/or transport to the cytosol [6]. 
have determined that it has a low K, value (0.4 PM) for 
SAH (unpublished). Using this enzyme, an assay for 
determining the relative levels of unmethylated cap 
structure in mRNA (GpppXpN---) has been developed. 
Using this assay, we have examined the effects of two 
adenosine analogs, neplanocin A (NPC) and 3- 
deazaneplanosin A (deazaNPC) (see structures, Fig. l), 
and the methionine analog ethionine on guanine-7- 
methylation of the cap structure. 
2. MATERIALS AND METHODS 
2.1. Materials 
Various adenosine analogs have been used to inhibit 
methylation of RNA by raising S-adenosylhomocys- 
teine (SAH) levels through the inhibition of SAH hydro- 
lase [7]. At elevated levels, SAH inhibits many meth- 
yltransferases resulting in the hypomethylation of 
mRNA and other RNAs as well. However, it has been 
reported that the adenosine analog Neplanocin A 
(NPC) does not inhibit the guanine-7-methylation of the 
cap structure even though it produced elevated SAH 
levels in the cell [8]. Similarly, the SAH analog S-tuber- 
cidinyl-homocysteine reportedly failed to inhibit the 
guanine methylation of the cap [6]. In both cases, while 
the 2’-O-methylation sites in the cap structure and inter- 
nal N6-methyladenosine sites were inhibited with these 
analogs, the important guanine-7-methylation was not 
affected. 
Chemically synthesized neplanocin A [lo] and deazaneplanocin A 
[1 l] (see structures, Fig. 1) were kindly provided by Dr. Victor E. 
Marquez, National Cancer Institute. All other chemicals were reagent 
grade. Radioactive [methyl-3H]-S-adenosylmethionine was purchased 
from Du Pont with a specific activity of l&15 Ciimmol. 
2.2. Guanine-7-methyltransferase 
We have partially purified the (guanine-7-)methyl- 
transferase from mouse Ehrlich ascites cells [9] and 
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The (guanine-7-)methyltransferase was prepared from nuclei iso- 
lated from Ehrlich ascites cells grown in ICR mice [9]. Ten grams of 
nuclei were isolated [12] and suspended in 60 ml of hypotonic buffer-I 
(10 mM Tris-HCl, pH 8.0, 10 mM KCl, 1 mM DTE, 2 mM EDTA, 
and 10% (v/v) glycerol). The proteinase inhibitor, PMSF (60 mM, 
dissolved in acetone and stored at -20°C was added to a final concen- 
tration of 1 mM. The nuclei were disrupted by 10 sonication cycles (a 
Fisher Sonic Dismembrator-Model300 with a microprobe was used); 
a 20-s sonication followed by 40 s of cooling in an ice slurry. The 
sonicated nuclear suspension was centrifuged at 100,000 x g for 2 h. 
The nuclear supematant was adjusted to 0.2 M NaCl and forced 
through a DEAE-Sephadex column (0.7 x 5 cm) with a syringe. The 
guanine-7- methyltransferase that passed through the column was 
purified about 8- to IO-fold and the endogenous nucleic acids were 
removed. This enzyme preparation was dialyzed (2 x 500 ml) over- 
night against enzyme storage buffer (hypotonic buffer-1 containing 
50% glycerol) and stored at -20°C. 
2.3. Post-polysomal RNA 
Post-polysomal supematant RNA was prepared by homogenizing 
tissue or cells in a hypotonic buffer-II (10 mM Tris-HCl, pH 7.9, 10 
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Fig. 1. Structures of adenosine analogs, neplanocin A (NPC) and 3-deazaneplanocin A (deazaNPC) 
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mM NaCl, 5 mM MgCl,, and 1% Triton X-100) to break the cells. The 
homogenate was centrifuged at 1,000 x g for 10 min to pellet nuclei 
and cell debris and then at 20,000 x g for 20 min to remove mitochon- 
dria and lysosomes. The supernate was collected and centrifuged at 
100,000 x g for 2 h to pellet polysomes. The post-polysomal fraction 
was mixed with 3 ~01s. of sodium dodecyl sulfate (SDS) buffer (50 mM 
sodium acetate, pH 5.1,0.14 M NaCl, and 0.3% (w/v) SDS) and4 vols. 
of phenol-cresol solution [13]. The resulting mixture was heated to 
55°C with continuous stirring and cooled to room temperature on me. 
The solution was stirred for an additional 30 min at room temperature 
and the phases were separated by centrifugation at 2,000 x g for 30 
min. The aqueous phase was collected and the RNA was precipitated 
wnh 2.5 ~01s. of 95% ethanol (2% potassium acetate) at -20°C over- 
night. The RNA was collected by centrifugatron and drssolved in 
autoclaved H,O. The concentration was determined by measuring the 
absorbance at 260 nm (E&,=200). 
2.4. Ttssue culture 
Normal rat kidney (NRK) cells were cultured at 37°C in Auto-Pow 
MEM (Flow Laboratories) supplemented with 5% fetal calf serum and 
25 lug/ml gentamicin in an atmosphere of sir/5% CO2 [13]. When 
cultures at about passage 60 were 90% confluent, fresh media was 
added with various concentrations of adenosine analogs (NPC or 
deazaNPC). The cells were harvested after 24 h and the post-pol- 
ysomal RNA was isolated as described above. 
2.5. Methyltransferase assa) 
The methyltransferase assay contained 100 ~1 of the enzyme prepa- 
ration, 1.4pM [‘HISAM (lo-15 Cilmmol). 0.05 M KCl, and 25 pg or 
50 pg of post-polysomal RNA (the activity was proportional to RNA 
over the range from 10 pg to 200 pg) in a final volume of 150 ~1. The 
assays were incubated at 37°C for 40 min (the reaction was linear for 
60 min). The reactions were stopped by adding 200 pg of yeast tRNA 
as carrier in 0.5 ml of SDS buffer plus 0.5 ml of phenolcresol to 
extract the RNA as described above. The RNA was repeatedly (four 
times) precipitated with ethanol and dissolved in H,O to remove radi- 
oactive SAM. To determine total methyltransferase acttvity, the RNA 
was precipitated again with ethanol and the pellet was dissolved in 0.5 
ml of H,O and the total radioactivity was determined by liquid scintil- 
latton counting. The isolated RNA was dissolved in 500 ~1 of freshly 
prepared 0.3 N NaOH and incubated at 37°C for 16 h to hydrolyze 
the RNA (the cap structure is resistant to hydrolysis) in order to 
determine the type of methylation. The digested sample was drluted 
with 45 ml of urea buffer (25 mM Tris-HCl. pH 7.5 and 7 M urea) and 
apphed to a DEAE-Sephadex column (0.7 x 20 cm) that had been 
equilibrated with urea buffer at a flow rate of about 1 ml/min. The 
column was washed with 10 ml of urea buffer and the oligonucleotides 
were eluted with a 200 ml linear salt gradient (O-0.4 M NaCl in urea 
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buffer) [14]. Three-milliliter fractions were collected and the UV ab- 
sorbance at 260 nm and radioactivity of each fraction were deter- 
mined. Cap structures were eluted at about mid-point of the salt- 
gradient. The peaks of radioactivity eluting from the column corre- 
spond to the amount of in vivo hypomethylation in that RNA fraction. 
i.e. high radioactivrty in the cap structures is proportional to a low 
level of methylation of these structures in the cell as a result of treat- 
ment with an analog. 
2.6. Ethromne treatment 
Mice (ICR mice 667 weeks old, about 30-35 g) were mjected m- 
traperitoneally with L-ethionine (125 mg/kg body weight) and adenine 
(120 mg/kg body weight) in 1 ml of sterile saline [9.15]. These injections 
were repeated twice at 24 h intervals and then the animals were sacri- 
ficed after another 24 h. The livers were removed and washed in cold 
saline and the post-polysomal RNA (methyl-deficient) was isolated. 
3. RESULTS 
The relative levels of unmodified methyl-acceptor 
groups in various post-polysomal RNA preparations 
were determined by incubating RNA with nuclear 
methyltransferase. The total levels of methyl-acceptor 
groups was determined in NRK cells treated with differ- 
ent concentrations of adenosine analogs, NPC and 
deazaNPC (Fig. 2). Both analogs had a IC,, of about 
0.5 PM and maximally inhibited methylation at 10 PM 
NPC or deazaNPC in the culture media. Cytotoxic ef- 
fects were observed with cells treated with 100 PM 
amounts of the adenosine analogs. 
Fig. 3A shows the DEAE-Sephadex column profiles 
of alkaline digested mouse liver post-polysomal RNA 
from control and ethionine-treated mice after incuba- 
tion with crude methyltransferase. The control RNA 
was a poor substrate for the methyltransferase while the 
RNA isolated from ethionine treated mice was an excel- 
lent methyl-acceptor with a double peak (fractions 20- 
35) representing cap structures with net charges of -5 
(cap 0, G”pppNp) and -6 (cap 1, G”pppN,pNp) and 
a small shoulder with a charge of -7 (cap 2, 
G”pppN,pN,pNp). There was a very small peak 
around fraction 3 with a charge of -2 (mononucleo- 
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Fig. 2. Total methyl-a~eptor levels m post-polysoma~ RNA Isolated from NRK cells treated with various levels of adenosine analogs (NPC, open 
bars and deazaNPC, hatched bars). RNA samples (25 pg) isolated from methyltransferase assays were preciprtated with ethanol (5x) to remove 
13H]SAM and the total radioactivity of each sample was determined. The control value (no adenosine analog) was 798 cpm (100%) and was the 
average of two flasks of cells. 
tides) resulting from the base methylation of nucleotides 
internal in the RNA sequence. 
Fig. 3B shows the DEAE-Sephadex column profiles 
of alkaline digested RNA from control and NPC- 
treated NRK cells. Cap 1 and cap 2 structures are the 
most prevalent with NPC treatment while ethionine 
treatment in mice produces mostly cap 0 and cap 1 
structures (Fig. 3A and B). NPC treatment also gener- 
ates many base h~omethylated sites on nucleotides in- 
ternal in tRNA (fraction 5, Fig. 3B). While hypomethyl- 
ation sites are low in control NRK cells (Figs. 2 and 3B) 
the levels are higher than seen in liver, consistent with 
hypomethylation levels previously observed with these 
tissue culture cells at this passage level [13]. 
The experiment was repeated using NPC treated cells 
and deazaNPC treated cells. NRK cells treated with 
deazaNPC, an adenosine analog that is not metabolized 
to its SAM analog, had similar levels of hypomethyla- 
tion as cells treated with NPC (Fig. 4). Again, a large 
peak of methylated nucleotides (N”p) was observed 
with both of these analogs. 
4. DISCUSSION 
We have previously used ethionine treatment of mice 
to produce methyl-deficient RNA (hypomethylated 
RNA) as a substrate for nuclear methyltransferases in- 
cluding the guanine-7-methyltransferase that methyl- 
ates the cap structure [9]. Ethionine inhibits methylation 
by its metabolism to the SAM analog S-adenosylethion- 
ine (SAE), which acts as a substrate analog for many 
methyltransferases causing an inhibition of methylation 
[I 51. Another inhibitor used in these experiments, NPC, 
is an adenosine analog (Fig. 1) that can inhibit the 
SAH-hydrolase [7] (metabolizes SAH to adenosine and 
hom~ysteine) resulting in a dramatic increase in cellu- 
lar SAH levels which can inhibit many methyltrans- 
ferases. NPC can also be metabolized to S-neplano- 
sylmethionine (SAM analog) and to S-neplanosylho- 
mocysteine (SAH analog) which could also cause inhibi- 
tion of methylation [7]. Another adenosine analog, 
deazaNPC, is not metabolized to its SAM and SAH 
analog and only elevates SAH levels by the inhibition 
of SAH-hydrolase [l 11. 
The multiple peaks of radioactivity that are resolved 
by column chromatography of digests of postpolysomal 
RNA correspond to the cap structures cap Q (-5 charge, 
G”pppNp), cap 1 (-6 charge, GmpppN~pNp) and cap 
2 (-7 charge, GmpppNmpNmpNp). The cap structures 
are resistant to alkaline digestion; however, the imi- 
dazole ring of guanine is opened at the 8-9 bond, con- 
verting 7-methylguanine to the ring-opened derivative, 
which lacks the positive charge [l]. Ethionine treatment 
generates RNA with more of the unmethylated cap 0 
structure than the adenosine analogs because of the 
apparent inhibition by SAE of the 2’-O-methyltrans- 
ferase that methylates the ribose in the nucleotide in the 
+I position of the RNA (Figs. 3 and 4). The 2’-O- 
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Fig. 3. Analysis of hydrolyzed-methylated RNA on DEAE-Sephadex columns. RNA (50 ,ug) isolated from a methyltransferase assay was digested 
with 0.3 N NaOH and applied to DEAE-Sephadex columns and nucleotides and ohgonucleotides were eluted with a o-0.4 M NaCl gradient (the 
gradient started at fraction 1 and ended at fraction 58). Panel A shows the data from mouse liver post-polysomal RNA (liver, 0) and ethionine 
treated mouse liver post-polysomal RNA (MD-liver, x) used as substrate for the methyltransferase. Panel B shows data from normal rat kidney 
post-polysomal RNA (NRK, q ) and neplanocin A treated NRK post-polysomal RNA (NPC-NRK, x). The position of the nucleotide peak is 
marked Np” (-2 charge) while the cap structures are marked: cap 0 (-5 charge), cap 1 (-6 charge) and cap 2 (-7 charge), 
methyltransfera~ that methylates the nucleotide in +l 
position of the RNA is apparently more sensitive to 
elevated SAE than to high SAH levels. However, the 
adenosine analogs generate more unmethylated sites in- 
ternal in the RNA sequences (N”‘p peak seen in Figs. 3b 
and 4, predominantly due to hypomethylated tRNA 
which is the most prevalent RNA in the post-polysomal 
fraction) than ethionine treatment. 
Since both adenosine analogs, NPC and deazaNPC, 
inhibit methylation to the same extent (Figs. 2 and 4), 
the inhibition of guanine-7-methylation f the cap struc- 
ture must be primarily due to the elevation of SAH. We 
have observed a low K, value (0.4 PM) for the inhibition 
of the isolated guanine-7-methyItransferase by SAH 
(unpublished). Because of the report that deazaNPC 
was a more potent inhibitor of the SAH hydrolase than 
NPC [16], we were surprised to find it caused identical 
maximal inhibition at 10 ,uM concentration (Figs. 2 and 
4). However, a more recent report has established that 
deazaNPC inhibits SAH hydrolase at about the same 
level as NPC [17], which agrees with our data. 
The earlier reports of the inability of NPC and S- 
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Fig. 4. DEAE-Sephadex column analysis of methylated RNA. Two samples of post-polysomal RNA isolated from NRK cells treated with 10pM 
neplanocin A (NPC, x) or deazaneplanocin A (deazaNPC, Cl) were used as substrate for the nuclear methyltransferase and digested and analyzed 
as in Fig. 3 except that a O-O.3 M NaCl gradient was used. The position of the nucleotide and cap peaks are marked Np” and cap respectively. 
tubercidinyl homocysteine to inhibit the guanine-7- 
methylation in cap structure [6,8], may have been due 
to the analysis of poly A selected RNA. We have found 
that if the mRNA is not guanine-7-methylated it does 
not bind to ribosomes, i.e. non-guanine-7-methylated 
capped mRNA appears in the post-polysomal fraction 
and is rapidly degraded to fragments about 40 to 60 
nucleotides in size [9]. In this same study [9], we also 
found little unmethylated cap structure in the nuclear- 
RNA or polysomal-RNA, which is not surprising, as 
methylation in the 7-position of the guanine in the cap 
structure is required for ribosome binding [5]. 
The treatment of NRK cells with adenosine analogs 
resulted in similar levels of hypomethylation of cap 
structure as found in ethionine injection of mice. There- 
fore, the methylation of the guanine-7-methylation of 
cap structure in mRNA is sensitive to elevated SAH. We 
have found the use of the guanine-7-methyltransferase 
assay to be a sensitive method to detect unmethylated 
cap structures. 
Acknowledgements: This work was supported in part by the Jeffress 
Memorial Trust. 
REFERENCES 
111 
121 
Shatkin, A.J. (1976) Cell 9, 645-653. 
Ohno, M., Sakamoto, H. and Shimura, Y. (1987) Proc. Natl. 
Acad. Sci. USA 84, 5187-5191. 
[3] Both, G.W., Banerjee, A.K. and Shatkin, A.J. (1975) Proc. Natl. 
Acad. Sci. USA 72, 1189-l 193. 
[4] Shatkin, A.J. (1985) Cell 40, 223-224. 
[5] Shatkin, A.J., Faraichi, Y. and Sonenberg, N., in: Transmethyl- 
ation (E. Usdin, R.T. Bouchardt and C.R. Creveling, Eds.), 
Elsevier, Amsterdam, 1979, pp. 34350., 
[6] Camper, S.A., Albers, R.J., Coward, J.K. and Rottman, F.M. 
(1984) Mol. Cell. Biol. 4, 538-543. 
[A Keller, B.T. and Borchardt, R.T., in: Biological Methylation and 
Drug Design (R.T. Borchardt, CR. Creveling and P.M. Ueland, 
Eds.), Humana Press, Clifton, New Jersey, 1986, pp. 385-396. 
[8] Ransohoff, R.M., Narayan, P., Ayers, D.F., Rottman, F.M., and 
Nilsen, T.W. (1987) Antiviral Res. 7, 317-327. 
[9] Bu, G. and Sitz, T.O., in: Nucleic Acid Methylation (G.A. 
1101 
illI 
1121 
[I31 
1141 
1151 
[I61 
[I71 
Clawson, D.B. Willis, A. Weissbach and P.A. Jones, Eds.), Liss, 
New York, 1990, pp. 57-65. 
Lim, M.I. and Marquez, V.E. (1983) Tetrahedron Lett. 24,5559- 
5562. 
Tseng, C.K.H., Marquez, V.E., Fuller, R.W., Goldstein, B.M., 
Haines, D.R., McPherson, H., Parsons, J.L., Shannon, W.M., 
Amett, G., Hollingshead, M. and Driscoll, J.S. (1989) J. Med. 
Chem. 32, 1442-1446. 
Higashi, K., Hanasaki, N. and Sakanato, Y. (1978) Biochem. 
Biophys. Acta 520, 612-615. 
Sitz, T.O., Godburn, K.E., Somers, K.D., and Nazar, B.N. (1983) 
Cancer Res. 43, 5681-5686. 
Brownlee, G.G. (1972) Determination of Sequences in RNA, 
Elsevier, Amsterdam. 
Lu, L.W., Chiang, G.H., and Randerath, K. (1976)Nucleic Acids 
Res. 3, 2243-2253. 
Glazer, RI., Hartman, K.D., Knode, M.C., Richard, M.M., 
Chiang, P.K., Tseng, C.K.H. and Marquez, V.E. (1986) Biochem. 
Biophys. Res. Comm. 135, 688-694. 
Cools, M. and DeClercq, E. (1989) Biochem. Pharm. 38, 1061- 
1067. 
277 
